30th Anniversary

The year 2024 marks the 30th anniversary of Current Oncology, a peer-reviewed open access journal on clinical oncology. With an Impact Factor of 2.8 and a CiteScore of 3.3, the journal is covered in Scopus, SCIE (Web of Science), PubMed, MEDLINE, PMC, Embase, and other databases. The journal has published more than 3,800 papers from more than 17,200 authors, who are from 98 countries. More than 5,300 reviewers have reviewed the journal at least once. We value all contributions made by our editors, authors, and reviewers equally.

In honor of the journal’s 30th anniversary, we are reflecting on our past accomplishments and embarking on an exciting new chapter. We invite you to join us in celebrating this milestone for our journal and to explore the content we have prepared for you below.

30th Anniversary of Current Oncology Video

Journal History


The inaugural issue was released by Mutlimed Inc.

Current Oncology was published as a quarterly journal.

Current Oncology adopted a bimonthly publication schedule.

Current Oncology was indexed in PubMed and archived in PubMed Central.

Current Oncology was indexed by the Science Citation Index Expanded (SCIE)—Web of Science (Clarivate Analytics).

Current Oncology received its first Impact Factor (2010) of 1.820.

Current Oncology was indexed by MEDLINE—National Library of Medicine.

Current Oncology was published by MDPI from Volume 28, Issue 1 (2021).

Prof. Dr. Sharlene Gill was appointed as Editor-in-Chief.

Current Oncology became an affiliated journal of the Canadian Association of Psychosocial Oncology (CAPO).

Current Oncology received a CiteScore (2020) of 3.8 and an Impact Factor (2020) of 3.677.

Fifteen sections were established.

Current Oncology announced the first edition of the Young Investigator Award, Outstanding Reviewer Award and Travel Award.

Current Oncology received a CiteScore (2021) of 3.5 and an updated Impact Factor (2021) of 3.109.

Current Oncology changed publication frequency from bimonthly to monthly.

Current Oncology became an affiliated journal of the Canadian Leukemia Study Group (CLSG).

Three sections were established.

Current Oncology received its 2022 Impact Factor (2.6) and CiteScore (2022) of 2.6.

Prof. Dr. Shahid Ahmed was appointed as Editor-in-Chief.

Current Oncology announced the 2023 Travel Award, 2023 Young Investigator Award, and 2023 Outstanding Reviewer Award.

Current Oncology received an Impact Factor (2023) of 2.8 and now ranks in Q2.

2024 marked the 30th anniversary of Current Oncology.

Current Oncology became an affiliated journal of the Canadian Centre for Applied Research in Cancer Control (ARCC).

Current Oncology received a CiteScore (2023) of 3.3.

Key Figures

582
Academic Editors
98
Author Distribution
17,232
Authors
3.3
Cite Score
2.6
Impact Factor
5,217,415
Page Views
34,797
Total Citations
3,062,200
Total Downloads

Testimonials

The Canadian Association for Psychosocial Oncology (CAPO) would like to recognize the outstanding achievements of the Current Oncology journal, as it celebrates its 30th year. We are so pleased and proud

[...] Read more.

The year 2024 marks the 30th anniversary of the journal, Current Oncology, an international, scientific, peer-reviewed, open access journal published bi-monthly. The Canadian Association of Medical Oncologists and its

[...] Read more.

I am a post-doctoral researcher and senior nuclear medicine specialist at the Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria. My

[...] Read more.


View All...

Top 10 Cited Papers

Immunotherapy in Gastric Cancer
by Anica Högner and Markus Moehler
ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date
by Sébastien Gendarme, Olivier Bylicki, Christos Chouaid and Florian Guisier
View All...

Anniversary Special Issues

The 30th Anniversary of Current Oncology: Perspectives in Clinical Oncology Practice
edited by
submission deadline 31 Oct 2024 | 8 articles | Viewed by 8832 | Submission Open
Keywords: clinical oncology; cancers; clinical trials

Special Issue Collection

News

1. Current Oncology | Affiliated Societies Collaboration

We are pleased to announce that we have established collaboration with the following 6 societies:

Canadian Association of General Practitioners in Oncology (CAGPO-ACMOO)

Canadian Association of Medical Oncologists (CAMO)

Canadian Association of Psychosocial Oncology (CAPO) - Association Canadienne d'Oncologie Psychosociale (ACOP)

Canadian Centre for Applied Research in Cancer Control (ARCC)

Canadian Leukemia Study Group (CLSG)

Cell Therapy Transplant Canada (CTTC)

As part of this collaboration, all members of the societies above will enjoy a discount on the Article Processing Charge (APC) when submitting articles to Current Oncology. The collaboration goes beyond the discount benefit offered to members and includes other services as well as cross-promotions.

Please visit the following link for more information: https://www.mdpi.com/journal/curroncol/societies


2. Welcoming the New Section Editors-in-Chief of Current Oncology

We are pleased to announce that Prof. Dr. Matthias May, Prof. Dr. Katrin Scheinemann, and Dr. Stuart Peacock have been appointed Editors-in-Chief of the Sections “Genitourinary Oncology”, “Childhood, Adolescent and Young Adult Oncology”, and “Health Economics”, respectively. We look forward to their contributions to Current Oncology (ISSN: 1718-7729).

Name: Prof. Dr. Matthias May

Affiliation: Department of Urology, St. Elisabeth Hospital Straubing, 94315 Straubing, Germany
Interests: bladder cancer; prostate cancer; renal cell carcinoma; robot-assisted surgery; biomarker-based oncology studies; prognostic outcome models; translational research, multicenter projects in genitourinary oncology research

Name: Prof. Dr. Katrin Scheinemann
Affiliation: Division of Hematology/Oncology, Children’s Hospital of Eastern Switzerland, 9006 St. Gallen, Switzerland
Interests: survivorship; long-term follow-up care; neurooncology; AYA oncology

Name: Prof. Dr. Stuart Peacock

Affiliation: 1. Leslie Diamond Chair in Cancer Survivorship, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada
2. Cancer Control Research, BC Cancer, Vancouver, BC V5Z 1L3, Canada
3. Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, BC V5Z 1L3, Canada
Interests: cancer survivorship; health economics; quality of life; priority setting; public engagement

Back to TopTop